Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-β signalling via secretion of bone morphogenetic protein 7. [electronic resource]
- Diabetes & vascular disease research Jul 2014
- 251-261 p. digital